Clinical trial
Effect and Mechanism of Acupuncture for Cancer-related Cognitive Difficulties (ENHANCE)
NCT04837820 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect and Mechanism of Acupuncture for Cancer-related Cognitive Difficulties (ENHANCE)
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Phase
- Phase 2
- Overall status
- Active, not recruiting
- Start date
- April 6, 2021
- Completion date
- April 30, 2027
- Enrollment
- 270 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer